Abstract:Key PointsZebrafish have an adaptive immune system that comprises both T and B cells. The molecular pathways that regulate the development and maturation of these lymphoid-cell populations have been highly conserved throughout evolution.The zebrafish is a powerful genetic model for dissecting the pathways that regulate erythrocyte and leukocyte development.Genetic screens have identified mutations that perturb normal thymic and T-cell development, most of which result in severe cranio-facial defects. This indicates that many of these mutations affect pharyngeal-arch development and, subsequently, that the thymic anlage fails to form in mutated embryos.Although the main advantage of using the zebrafish model system lies in the ability to carry out forward-genetic screens, the zebrafish model also offers many other advantages for studying thymic and T-cell development.Transgenic zebrafish have been created that have green fluorescent protein (GFP)-labelled T cells, which allow the visualization of thymocyte development and function in a living organism. In conjunction with cell transplantation, transgenic approaches have provided unique reagents for the study of T-cell homing and the assessment of haematopoietic stem-cell function.Reverse-genetic approaches rely on the targeted inactivation of gene products in developing organisms. Because gene-knockout technology has yet to be developed in zebrafish, researchers can use either targeting induced local lesions in genomes (TILLING) or morpholino antisense oligonucleotides to disrupt gene function in developing embryos.TILLING is a technique that uses N-ethyl-N-nitrosourea mutagenesis and the sequencing of genomic DNA to detect point mutations that are present in a gene of interest. This technology has been used successfully to disrupt recombination-activating gene 1 (rag1) gene function in zebrafish, which alters immune function in homozygous mutant individuals.Morpholinos are chemically modified antisense oligonucleotides that can be microinjected into one-cell-stage embryos. Because of their long half-life, these molecules can disrupt gene function for up to 5 days.The high-throughput sequencing of cDNA libraries in conjunction with whole-mount in situ hybridization has allowed researchers to carry out expression-based screens in zebrafish embryos, which provide new avenues for gene discovery.Small-molecule-inhibitor screens have been used to identify water-soluble compounds that can be taken up by living zebrafish larvae and can restore mutant gene function in embryos. Because T-cell ablation can be monitored in rag2–GFP- and light-chain kinase (lck)–GFP-transgenic fish, and because dexamethasone treatment results in the loss of fluorescently labelled thymocytes, it might be possible to carry out small-molecule-inhibitor screens that are designed to identify drugs that selectively kill thymocytes, which might identify new immunosuppressive drugs.

Mimicking TGFBI Hot-Spot Mutation Did Not Result in Any Deposit Formation in the Zebrafish Cornea

Zebrafish ( ) mutants provide a preclinical model for macular corneal dystrophy

Generation of mouse model of TGFBI-R124C corneal dystrophy using CRISPR/Cas9-mediated homology-directed repair

CRISPR/Cas9 in zebrafish: An attractive model for FBN1 genetic defects in humans

Investigation of the Influence of Arg555Trp and Thr538Pro TGFBI Mutations on C-terminal Cleavage and Cell Endoplasmic Reticulum Stress.

CRISPR/Cas9 Sistemi Kullanılarak Ectodysplasin A (eda) İfade Etmeyen Zebra Balığı Üretimi

Zebrafish Model of Stickler Syndrome Suggests a Role for Col2a1a in the Neural Crest during Early Eye Development

A CRISPR-Cas9-mediated F0 screen to identify pro-regenerative genes in the zebrafish retinal pigment epithelium

Establishment of a Transgenic Mouse Model of Corneal Dystrophy Overexpressing Human BIGH3.

Ciliary genes arl13b, ahi1 and cc2d2a differentially modify expression of visual acuity phenotypes but do not enhance retinal degeneration due to mutation of cep290 in zebrafish

[Generation of Tnnt2a Knock-out Zebrafish Via CRISPR/Cas9 and Phenotypic Analysis].

Analysis of novel domain-specific mutations in the zebrafish ndr2/cyclops gene generated using CRISPR-Cas9 RNPs

Knockdown of Ttc26 Disrupts Ciliogenesis of the Photoreceptor Cells and the Pronephros in Zebrafish.

Establishment and Preliminary Mechanism Study of the Zebrafish Strain of KIAA0196: A Candidate Pathogenic Gene for Heart Development

Transgenic Expression of A Venous Malformation Related Mutation, TIE2-R849W, Significantly Induces Multiple Malformations of Zebrafish

Characterization of a novel zebrafish model of -associated CMT4B3

A transgenic zebrafish for <i>in vivo</i> visualization of cilia

Establishment of Zebrafish Model Via TIE2-R849W and Exploration of Its Role in Hereditary Venous Malformations

The zebrafish: a new model of T-cell and thymic development

Knockout of miR-184 in zebrafish leads to ocular abnormalities by elevating p21 levels

Abstract 1430: Development of transparent transgenic zebrafish model to study anti-cancer drug induced in vivo cardiotoxicity